Kim Rathmell, MD
Investigator
Associate Professor
rathmell@med.unc.edu
UNC Profile
Phone: (919) 966-8644
University of North Carolina at Chapel Hill

21-237 Lineberger Comprehensive Cancer Center
CB #7295
Chapel Hill, NC 27599-7295

Dr. Rathmell is Associate Professor Department of Genetics at the University of North Carolina at Chapel Hill. Her expertise is in renal cell carcinoma, con Hippel-Landau tumor suppressor gene, and biologically active treatment protocols.
Journal Article
Trastuzumab emtansine versus capecitabine plus lapatinib in patients with previously treated HER2-positive advanced breast cancer (EMILIA): a descriptive analysis of final overall survival results from a randomised, open-label, phase 3 trial., Diéras V, Miles D, Verma S, Pegram M, Welslau M, Baselga J, Krop IE, Blackwell K, Hoersch S, Xu J, Green M, Gianni L, Lancet Oncol, Volume 18, 2017 Jun, Issue 6, p.732-742. (2017) PubMed